• Featured Documentary: A Solid Dosage Future

    While biopharmaceuticals continue to grab much of the limelight in the pharmaceutical industry, the fact is solid dosage products (tablets, capsules, pills, etc.) still account for the majority of medicinal products made worldwide. The reasons for this market share are abundantly clear: patients are familiar with the dosage form and are comfortable using it. In addition, the industry has many decades of experience designing, formulating, testing, manufacturing and packaging solid dosage products. The knowledge base is extensive. read more
  • Watch Video: The Clean Facility of the Future - Advanced Microbiology Techniques for Cleaner Facilities and Purer Products

    Learn about the tools, techniques, services and best practices being used to manufacture high quality products while minimizing contamination and error in the Clean Facility of the Future Documentary. read more
  • Cleaning & Disinfection in Biopharma: Cutting Contamination Risk

    Wednesday, May 20, 2026
    As biopharmaceutical processes become more biologically complex and operationally interconnected, the impact of contamination events continues to grow. Cell and gene therapies, multiproduct facilities, single-use systems and accelerated timelines have raised the stakes, and regulators now expect ...
  • Recent Advances in Crystalline Polymorphism Research in Drug Development

    Thursday, April 09, 2026
    This webinar explores recent advancements in crystal screening and characterization for pharmaceutical development.
  • Implementation of Global Microbiology QC Automation at Amgen

    Friday, April 03, 2026
    In this webinar learn how Amgen transformed its global QC Microbiology operations by implementing the Growth Direct® platform to fully automate in-process bioburden, water bioburden, and environmental monitoring testing.
  • Validating Automated Alternative Rapid Sterility Methods

    Wednesday, December 17, 2025
    This webinar will provide an overview of the on-site validation approach used by Rapid Micro Biosystems™ to demonstrate that the Growth Direct® Rapid Sterility System, is equivalent or non-inferior, to the compendial sterility test described in the Pharmacopeia.